Ing Groep Nv Johnson & Johnson Transaction History

Ing Groep Nv

$16.5 Billion
Q2 2024

A detailed history of Ing Groep Nv transactions in Johnson & Johnson stock. As of the latest transaction made, Ing Groep Nv holds 502,078 shares of JNJ stock, worth $83.1 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

502,078

Previous 794,947 36.84%

Holding current value

$83.1 Million

Previous $126 Million 41.64%

% of portfolio

0.45%

Previous 0.88%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $42.3 Million - $46.2 Million	-292,869 Reduced 36.84%	502,078 $73.4 Million
Q1 2024 May 10, 2024	BUY	$155.22 - $162.74 $49 Million - $51.4 Million	315,579 Added 65.83%	794,947 $126 Million
Q4 2023 Feb 08, 2024	BUY	$145.6 - $158.88 $2.15 Million - $2.34 Million	14,746 Added 3.17%	479,368 $75.1 Million
Q3 2023 Oct 27, 2023	SELL	$155.75 - $174.48 $95.7 Million - $107 Million	-614,324 Reduced 56.94%	464,622 $72.4 Million
Q2 2023 Aug 07, 2023	BUY	$154.35 - $166.11 $5.41 Million - $5.82 Million	35,018 Added 3.35%	1,078,946 $179 Million
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $9.4 Million - $11.2 Million	-62,247 Reduced 5.63%	1,043,928 $162 Million
Q4 2022 Feb 10, 2023	BUY	$160.2 - $179.79 $110 Million - $124 Million	688,896 Added 165.09%	1,106,175 $195 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $9.87 Million - $11 Million	-61,187 Reduced 12.79%	417,279 $68.2 Million
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $13.5 Million - $14.9 Million	-80,006 Reduced 14.33%	478,466 $84.9 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $16.4 Million - $18.7 Million	103,872 Added 22.85%	558,472 $99 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $30.1 Million - $33.4 Million	193,039 Added 73.8%	454,600 $77.8 Million
Q3 2021 Nov 02, 2021	BUY	$161.5 - $179.47 $2.63 Million - $2.92 Million	16,282 Added 6.64%	261,561 $42.2 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $6.17 Million - $6.62 Million	38,672 Added 18.72%	245,279 $40.4 Million
Q1 2021 May 12, 2021	SELL	$153.07 - $170.48 $531,152 - $591,565	-3,470 Reduced 1.65%	206,607 $34 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $10.5 Million - $12 Million	-76,385 Reduced 26.66%	210,077 $33.1 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $32.1 Million - $35.2 Million	228,513 Added 394.33%	286,462 $42.6 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $54.8 Million - $66.1 Million	-425,094 Reduced 88.0%	57,949 $8.15 Million
Q1 2020 May 06, 2020	SELL	$111.14 - $153.99 $1.44 Million - $1.99 Million	-12,933 Reduced 2.61%	483,043 $63.3 Million
Q4 2019 Feb 10, 2020	SELL	$127.5 - $146.44 $1.55 Million - $1.78 Million	-12,131 Reduced 2.39%	495,976 $72.3 Million
Q3 2019 Nov 08, 2019	SELL	$126.95 - $142.14 $32.9 Million - $36.8 Million	-258,806 Reduced 33.75%	508,107 $65.7 Million
Q2 2019 Aug 12, 2019	SELL	$131.15 - $144.24 $46.3 Million - $50.9 Million	-352,840 Reduced 31.51%	766,913 $107 Million
Q1 2019 May 13, 2019	BUY	$125.72 - $139.79 $64.1 Million - $71.2 Million	509,628 Added 83.53%	1,119,753 $157 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $1.69 Million - $2.04 Million	13,795 Added 2.31%	610,125 $78.7 Million
Q3 2018 Nov 06, 2018	BUY	$121.58 - $142.88 $5.64 Million - $6.63 Million	46,369 Added 8.43%	596,330 $82.4 Million
Q2 2018 Aug 10, 2018	SELL	$119.4 - $131.76 $36.2 Million - $40 Million	-303,352 Reduced 35.55%	549,961 $66.7 Million
Q1 2018 May 07, 2018	BUY	$125.1 - $148.14 $64.5 Million - $76.4 Million	515,503 Added 152.6%	853,313 $109 Million
Q4 2017 Feb 06, 2018	SELL	$131.22 - $143.62 $44.4 Million - $48.6 Million	-338,578 Reduced 50.06%	337,810 $47.2 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $87.6 Million - $91.6 Million	676,388	676,388 $87.9 Million

Others Institutions Holding JNJ

# of Institutions

4,160

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $433B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account